Update (August 19): The panel has rejected 13 of the 14 proposals it has considered thus far, The Washington Post reports.
More than a year after the Department of Health and Human Services announced the creation of the National Institutes of Health Human Fetal Tissue Research Ethics Advisory Board, members of the committee convened for the first time on Friday (July 31) to oversee the ethics of using fetal tissue in federally funded research. Of the 15 committee members, appointed by President Donald Trump, 10 have a history of activism against abortion or fetal tissue use. As Buzzfeed News reports, some researchers have voiced concerns that the panel could impair future research on HIV, diabetes, COVID-19 vaccines, and more.
The board’s purpose is to review research grant proposals that study human fetal tissue (HFT) and advise that they receive funding only if no adequate alternatives exist ...